Innate Pharma
Clinical-stage biotech developing immunotherapies for cancer using the innate immune system.
IPH | PA
Overview
Corporate Details
- ISIN(s):
- FR0010331421 (+1 more)
- LEI:
- 9695002Y8420ZB8HJE29
- Country:
- France
- Address:
- 117 AVENUE DE LUMINY, 13009 MARSEILLE
- Website:
- http://www.innate-pharma.com/
- Sector:
- Manufacturing
Description
Innate Pharma is a clinical-stage, oncology-focused biotechnology company that develops immunotherapies for cancer patients. The company's scientific approach is centered on leveraging the innate immune system, particularly Natural Killer (NK) cells, to create novel treatments. Its innovative pipeline is composed of antibody-based therapeutics, including first-in-class monoclonal antibodies, antibody-drug conjugates (ADCs), and multi-specific NK cell engagers based on its proprietary ANKET® platform. Key clinical programs include lacutamab (anti-KIR3DL2), monalizumab (anti-NKG2A) in partnership with AstraZeneca, and a portfolio of NK cell engagers targeting various hematological malignancies and solid tumors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-08-12 07:00 |
Nouveau nombre d'actions et de droits de vote d'Innate Pharma au 1er août 2020
|
French | 175.5 KB | ||
| 2020-08-11 07:00 |
Innate Pharma obtient un financement public de 6,8M€ pour ses activités de rech…
|
French | 401.6 KB | ||
| 2020-08-11 07:00 |
Innate Pharma obtains €6.8M in public funding for its COVID-19 research and dev…
|
English | 495.3 KB | ||
| 2020-07-29 11:30 |
INNATE PHARMA ANNOUNCES PUBLICATION OF EXPLORE COVID-19 TRANSLATIONAL STUDY FIN…
|
English | 109.5 KB | ||
| 2020-07-29 11:30 |
INNATE PHARMA ANNONCE LA PUBLICATION DANS NATURE DES RESULTATS DE L’ETUDE TRANS…
|
French | 86.7 KB | ||
| 2020-07-16 07:00 |
Innate Pharma annonce la nomination de Joyson Karakunnel, MD, MSC, FACP, au pos…
|
French | 212.6 KB | ||
| 2020-07-16 07:00 |
Innate Pharma announces the appointment of Joyson Karakunnel, MD, MSC, FACP as …
|
English | 382.5 KB | ||
| 2020-06-24 07:00 |
U.S. Food and Drug Administration lifts partial clinical hold on lacutamab TELL…
|
English | 408.3 KB | ||
| 2020-06-24 07:00 |
L'agence américaine du médicament lève la suspension partielle de l'essai TELLO…
|
French | 242.9 KB | ||
| 2020-05-12 07:00 |
Innate Pharma First Quarter 2020 Report
|
English | 221.9 KB | ||
| 2020-01-13 23:00 |
French regulatory agency agrees lacutamab TELLOMAK trial can resume recruitment…
|
English | 202.3 KB | ||
| 2020-01-13 23:00 |
L’agence réglementaire française autorise la reprise du recrutement dans l’essa…
|
French | 175.0 KB | ||
| 2020-01-09 07:00 |
INNATE PHARMA PROVIDES UPDATE FROM REGULATORY AGENCIES ON LACUTAMAB TELLOMAK T…
|
French | 195.9 KB | ||
| 2020-01-02 07:00 |
L'agence européenne du médicament accepte le dossier de demande d'enregistremen…
|
French | 176.9 KB | ||
| 2020-01-02 07:00 |
The European Medicines Agency accepts the regulatory submission for Lumoxiti in…
|
English | 250.5 KB |
Automate Your Workflow. Get a real-time feed of all Innate Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Innate Pharma
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Innate Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-10 | N/A | Other | Buy | 6,000 | N/A |
| 2024-01-02 | N/A | Other | Buy | 20,000 | N/A |
Peer Companies
